Drug Risperdal May be Linked to Development of Female Breasts in Boys

Risperdal is a drug that treats schizophrenia and certain problems caused by bipolar disorder.

It’s also a drug that has led to an increasing number of lawsuits amid claims it caused young boys to develop breasts.

Personal injury lawyers are working on a number of cases on behalf of young boys who have allegedly developed male breast tissue due to their use of the antipsychotic drug Risperdal. The lawsuits allege that Johnson & Johnson failed to provide adequate warnings about this risk and failed to properly research the side effects of the drug.

It’s not the first time Johnson & Johnson has faced legal action on this drug and other drugs and devices.

In recent months, the giant pharmaceuticals company lost three consecutive class action lawsuits over its marketing tactics for Risperdal (generic: risperidone).

The company settled an individual Risperdal lawsuit filed on behalf of a young man who developed female breasts in September 2012, after he was treated with the drug over five years. If you are suffering from this debilitating condition you are not alone.

Johnson & Johnson has come under fire for its flawed hip transplants that left many patients with terrible complications.

Under an agreement made last year, the medical products giant agreed to pay $2.5 billion in compensation to an estimated 8,000 patients who have been forced to have the all-metal artificial hip removed and replaced with another device.

Time after time our Virginia dangerous drugs injury lawyers see examples of big pharmaceutical companies putting profits before the safety of those who use their products.

If you have been hurt by a dangerous drug or another product, call Cooper Hurley Injury Lawyers at 757.455.0077 or see Cooperhurley.com.